Quarterly report pursuant to Section 13 or 15(d)

Supplemental Cash Flow Information

v2.4.1.9
Supplemental Cash Flow Information
 3 Months Ended
Mar. 31, 2015
Notes  
Supplemental Cash Flow Information

11.  SUPPLEMENTAL CASH FLOW INFORMATION

 

 

Three Months ended

March 31,

 

2015

 

2014

Cash paid for interest

$

12,557

 

$

39,116

Series C Dividend payable in accrued expenses

$

--

 

$

17,574

Series D Dividend payable in accrued expenses

$

15,819

 

$

45,665

 

 

 

 

 

 

Non-Cash investing and financing transactions

 

 

 

 

 

Shares issued for consulting services

$

25,500

 

$

--

Beneficial conversion feature on warrants issued in

conjunction with Series D preferred shares

$

--

 

$

13,347

Shares issued in acquisition of Dr. Pave

$

--

 

$

175,000